Documentation Centre

 

 

  of 148 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Intensive versus conventional glycemic control: what is best for patients with type 2 diabetes? Diabetes Metab Syndr 2013;7:48-51 May 22, 2013 Intensive versus conventional glycemic control: what is best for patients with type 2 diabetes? Diabetes Metab Syndr 2013;7:48-51 Ahmed AA, Alsharief E, Alsharief A. Key Publications
Exploring the promise of resveratrol: where do we go from here? Diabetes 2013;62:1022-3 May 16, 2013 Exploring the promise of resveratrol: where do we go from here? Diabetes 2013;62:1022-3 Crandall JP, Barzilai N. Key Publications
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 2013;62:1186-95 May 15, 2013 High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 2013;62:1186-95 Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, Møller N, Jessen N, Pedersen SB, Jørgensen JO. Key Publications
Does diet-beverage intake affect dietary consumption patterns? Results from the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. Am J Clin Nutr 2013;97:604-11 April 12, 2013 Does diet-beverage intake affect dietary consumption patterns? Results from the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. Am J Clin Nutr 2013;97:604-11 Piernas C, Tate DF, Wang X, Popkin BM. Key Publications
Lipids: Dalcetrapib raises HDL-cholesterol level, but does not reduce cardiac risk. Nat Rev Cardiol 2012;10:5 February 11, 2013 Lipids: Dalcetrapib raises HDL-cholesterol level, but does not reduce cardiac risk. Nat Rev Cardiol 2012;10:5 Lim GB. Key Publications
Lipids: Antibodies against PCSK9-a new era of therapy. Nat Rev Cardiol 2012;10:1 February 11, 2013 Lipids: Antibodies against PCSK9-a new era of therapy. Nat Rev Cardiol 2012;10:1 King A. Key Publications
Traditional risk factors alone could not explain the excess mortality in patients with diabetes: A national cohort study of older Spanish adults. Diabetes Care 2012;35:2503-9 January 22, 2013 Traditional risk factors alone could not explain the excess mortality in patients with diabetes: A national cohort study of older Spanish adults. Diabetes Care 2012;35:2503-9 Regidor E, Franch J, Seguí M, Serrano R, Rodríguez-Artalejo F, Artola S. Key Publications
Diabetes: Screening for T2DM does not reduce mortality. Nat Rev Endocrinol 2012;8:694 January 20, 2013 Diabetes: Screening for T2DM does not reduce mortality. Nat Rev Endocrinol 2012;8:694 Mitchell F. Key Publications
Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 2012;308:2001-11 January 19, 2013 Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 2012;308:2001-11 Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Tavazzi L, Tognoni G; OPERA Investigators. Key Publications
Novel circulating fatty acid patterns and risk of cardiovascular disease: the Cardiovascular Health Study. Am J Clin Nutr 2012;96:1252-61 January 17, 2013 Novel circulating fatty acid patterns and risk of cardiovascular disease: the Cardiovascular Health Study. Am J Clin Nutr 2012;96:1252-61 Imamura F, Lemaitre RN, King IB, Song X, Lichtenstein AH, Matthan NR, Herrington DM, Siscovick DS, Mozaffarian D. Key Publications

  of 148 Next page

Go to page: of